Himanshu Patni

  Erythropoietin Stimulating Agent Market Booms: Rising Anemia, Innovation, and Regional Growth The Erythropoietin Stimulating Agents (ESA) market is experiencing significant growth, projected to reach a value of USD 21.7 billion by 2030 at a CAGR of 8.6%. This rise is primarily driven by: Increasing prevalence of anemia:  Conditions like chronic kidney disease, cancer, and malnutrition contribute to the growing number of individuals suffering from anemia. According to the University of Texas MD Anderson Cancer Center, anemia is a common occurrence in cancer patients. Rising awareness and diagnosis:  Improved access to healthcare and growing awareness around anemia lead to earlier diagnosis and treatment. Technological advancements:  Darbepoetin-alfa, with its longer half-life requiring less frequent dosing, is driving market growth within the product type segment. Unlock Insights: Receive a Sample Research R...

  Advance Directives Devices Market Poised for Strong Growth, Driven by Rising Awareness and Chronic Disease Prevalence The global advance directives device market continues its upward trajectory, reaching a valuation of USD 113,946.86 million in 2022 and expected to grow at a robust Compound Annual Growth Rate (CAGR) of around 18.1% during the forecast period (2023-2030). This significant growth is primarily attributed to increasing public awareness surrounding the importance of advance directives. Initiatives like the Adirondack Death Care Community's (ADKDCC) January 2024 workshop in Saranac Village exemplify growing efforts to educate individuals about advance care planning (ACP) and empower them to make informed choices about their end-of-life care. Unlock Insights: Receive a Sample Research Report on the Advance Directives Devices Market: https://univdatos.com/get-a-free-sample-form-php/?product_id=54540 Advance directives typically comprise two key documents: ...